IndraLab
Statements
Hydroxychloroquine activates INS. 13 / 13
|
13
reach
"Patients with SLE taking an antimalarial agent have also been shown to have lower fasting blood glucose conentrations - a risk factor for premature atherosclerosis - compared with controls [XREF_BIBR], and one study demonstrated that hydroxychloroquine prolongs the half-life of the active insulin and receptor complex via inhibition of the insulin-receptor dissociation, thus augmenting insulin stimulated responses [XREF_BIBR]."
reach
"Proposed mechanisms include improving insulin sensitivity, enhancing insulin dependent glucose transport, and decreasing the degradation of intracellular insulin.S1 A study demonstrated that HCQ could increase insulin secretion and improve blood glucose levels in prediabetic patients.S2 Another trial also showed that chloroquine could lower glucose levels in diabetic patients with a similar mechanism.S3 HCQ induced hypoglycemia in the nondiabetic population is quite rare."